FDA permits study of cord blood stem cells for cerebral palsy

06/28/2010 | American City Business Journals

Dr. Joanne Kurtzberg, director of Duke University's Pediatric Bone Marrow and Transplant program, has been authorized by the FDA to conduct a randomized clinical study to test the efficacy of cord blood stem cells in treating pediatric patients with spastic cerebral palsy. The study could entice more parents to have their child's cord blood stored in private cord blood banks, Kurtzberg said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC